胆碱酯酶抑制剂在痴呆治疗中的应用现状

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer’s disease patients[J] . Elisa Conti,Gloria Galimberti,Lucio Tremolizzo,Alessandro Masetto,Diletta Cereda,Clara Zanchi,Fabrizio Piazza,Marco Casati,Valeria Isella,Ildebrando Appollonio,Carlo Ferrarese.Neuroscience Letters . 2010 (3)

Safety and efficacy of galantamine （Reminyl） in severe Alzheimer’s disease （the SERAD study）: a randomised, placebo-controlled, double-blind trial[J] . Lancet Neurology . 2009 (1)

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL[J] . Martin Dichgans,Hugh S Markus,Stephen Salloway,Auli Verkkoniemi,Margaret Moline,Qin Wang,Holly Posner,Hugues S Chabriat.Lancet Neurology . 2008 (4)

Galantamine treatment of vascular dementia: A randomized trial[J] . A P. Auchus,H R. Brashear,S Salloway,A D. Korczyn,P P. De Deyn,C Gassmann-Mayer.Neurology . 2007 (5)

Preliminary Findings: Behavioral Worsening on Donepezil in Patients With Frontotemporal Dementia[J] . Mario F. Mendez,Jill S. Shapira,Aaron McMurtray,Eliot Licht.American Journal of Geriatric Psychiatry . 2007 (1)

Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors[J] . Timo Erkinjuntti,Gustavo Román,Serge Gauthier.Journal of the Neurological Sciences . 2004 (1)

Long-term donepezil treatment in 565 patients with Alzheimer’s disease （AD2000）: randomised double-blind trial[J] . Courtney C,Farrell D,Gray R,Hills R,Lynch L,Sellwood E,Edwards S,Hardyman W,Raftery J,Crome P,Lendon C,Shaw H,Bentham P.The Lancet . 2004 (9427)

Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial[J] . Timo Erkinjuntti,Alexander Kurz,Serge Gauthier,Roger Bullock,Sean Lilienfeld,ChandrasekharRao Venkata Damaraju.The Lancet . 2002 (9314)

Efficacy and Safety of Rivastigmine in Patients with Alzheimer’s Disease: International Randomised Controlled Trial[J] . Michael R?sler,Ravi Anand,Ana Cicin-Sain,Serge Gauthier,Yves Agid,Peter Dal-Bianco,Hannes B. St?helin,Richard Hartman,Marguirguis Gharabawi.BMJ: British Medical Journal . 1999 (7184)

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer’s disease patients[J] . Elisa Conti,Gloria Galimberti,Lucio Tremolizzo,Alessandro Masetto,Diletta Cereda,Clara Zanchi,Fabrizio Piazza,Marco Casati,Valeria Isella,Ildebrando Appollonio,Carlo Ferrarese.Neuroscience Letters . 2010 (3)

Safety and efficacy of galantamine （Reminyl） in severe Alzheimer’s disease （the SERAD study）: a randomised, placebo-controlled, double-blind trial[J] . Lancet Neurology . 2009 (1)

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL[J] . Martin Dichgans,Hugh S Markus,Stephen Salloway,Auli Verkkoniemi,Margaret Moline,Qin Wang,Holly Posner,Hugues S Chabriat.Lancet Neurology . 2008 (4)

Galantamine treatment of vascular dementia: A randomized trial[J] . A P. Auchus,H R. Brashear,S Salloway,A D. Korczyn,P P. De Deyn,C Gassmann-Mayer.Neurology . 2007 (5)

Preliminary Findings: Behavioral Worsening on Donepezil in Patients With Frontotemporal Dementia[J] . Mario F. Mendez,Jill S. Shapira,Aaron McMurtray,Eliot Licht.American Journal of Geriatric Psychiatry . 2007 (1)

Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors[J] . Timo Erkinjuntti,Gustavo Román,Serge Gauthier.Journal of the Neurological Sciences . 2004 (1)

Long-term donepezil treatment in 565 patients with Alzheimer’s disease （AD2000）: randomised double-blind trial[J] . Courtney C,Farrell D,Gray R,Hills R,Lynch L,Sellwood E,Edwards S,Hardyman W,Raftery J,Crome P,Lendon C,Shaw H,Bentham P.The Lancet . 2004 (9427)

Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial[J] . Timo Erkinjuntti,Alexander Kurz,Serge Gauthier,Roger Bullock,Sean Lilienfeld,ChandrasekharRao Venkata Damaraju.The Lancet . 2002 (9314)

Efficacy and Safety of Rivastigmine in Patients with Alzheimer’s Disease: International Randomised Controlled Trial[J] . Michael R?sler,Ravi Anand,Ana Cicin-Sain,Serge Gauthier,Yves Agid,Peter Dal-Bianco,Hannes B. St?helin,Richard Hartman,Marguirguis Gharabawi.BMJ: British Medical Journal . 1999 (7184)